Neurological
Cancer

Oncology Solutions

In the United States, about 23,820 malignant tumors of the brain or spinal cord will be diagnosed in 2019.1 With the technological advances in the technology field, brain tumor imaging has become an essential component in managing the patients across the care pathway.

The Patient Journey

  • SIGNA™ Artist AIR™ Edition

    Our premium 1.5T, 70 cm wide bore MRI system leverages intelligent technology to enable patient-friendly exams with exceptional image quality.

  • SIGNA™ Architect AIR™ Edition

    Our premium 3.0T, 70 cm wide bore MRI system leverages intelligent technology to enable patient-friendly exams with exceptional image quality.

  • SIGNA™ Premier AIR™ Edition

    Our leading, innovative 3.0T MRI system brings you uncompromised 60 cm performance in a 70 cm wide bore for advanced imaging and research.

  • MR Radiation Oncology Suite

    Our MR Radiation Oncology Suite provides the tools designed to help you better target and treat tumors through consistent patient positioning.

  • PET VCAR

    Multi-modality, multi-exam comparison to evaluate lesion metabolic activity over time.

  • SIGNA™ PET/MR with QuantWorks – 60cm

    Introducing SIGNA™ PET/MR with QuantWorks. Built with pioneering TOF and integrated with a 3.0T MR, its impressive quantitative accuracy and high count rate combined with ...

The latest in Oncology


INSIGHTS
1. https://www.cancer.org/cancer/brain-spinal-cord-tumors-adults/about/key-statistics.html

JB02169UK